The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Biogen Idec to Report Second Quarter 2011 Financial Results on July 26, 2011

Thursday, July 07, 2011

Biogen Idec to Report Second Quarter 2011 Financial Results on July 26, 201114:18 EDT Thursday, July 07, 2011 WESTON, Mass. (Business Wire) -- Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report second quarter 2011 financial results on Tuesday, July 26, 2011, before the financial markets open. Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET. To access the live webcast, please go to the investor relations section of Biogen Idec's website at www.biogenidec.com. Following the live webcast, an archived version of the call will be available at the same URL, for one month. About Biogen Idec Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com. Biogen IdecKaren Jewell, 781-464-2442Investor Relations